Free PANCE Practice Questions

Reproductive PANCE practice questions

10 free, board-style Reproductive questions for the PANCE, each with the correct answer and a complete explanation. No email, no account required.

Reproductive is 7% of the PANCE content blueprint. These questions come from the clinician-reviewed FirstPassPA bank. Attempt each one before you reveal the answer.

Question 1ReproductiveMedium
A 15-year-old boy is brought in by his mother for a unilateral right breast lump and intermittent bloody nipple discharge over the past 2 months. He denies medication or supplement use, including anabolic steroids. Exam shows a firm, eccentric 2 cm mass beneath the right nipple, tender to palpation, with serosanguinous discharge expressible from the nipple; the contralateral breast is normal and Tanner stage is 4. There is no axillary lymphadenopathy and the testes are normal. Which of the following is the most appropriate next step in evaluation?
  • ASerum beta-hCG and testosterone
  • BCore needle biopsy of the mass
  • CMammography
  • DBreast ultrasound
  • EReassurance and reevaluation in 6 months
Reveal answer & full explanation
Correct answer: D — Breast ultrasound
  • ASerum beta-hCG and testosterone
  • BCore needle biopsy of the mass
  • CMammography
  • DBreast ultrasound✓
  • EReassurance and reevaluation in 6 months

Why Breast ultrasound is correct

  • Pubertal gynecomastia is common but is typically bilateral or asymmetric, rubbery, concentric, and non-bloody
  • Unilateral, eccentric, firm, or rapidly enlarging masses, and especially bloody nipple discharge, are red flags that mandate imaging to rule out a discrete lesion such as fibroadenoma, intraductal papilloma, or, rarely, a malignancy
  • In a male younger than 25, breast cancer is exceedingly rare and ultrasound is the preferred first study: the ACR Appropriateness Criteria rate it the initial study for an indeterminate breast mass below age 25 and rate it appropriate at any age when nipple discharge or another suspicious finding is present, and it characterizes the lesion without radiation

Why the others are wrong

  • Reassurance and reevaluation in 6 months — appropriate for typical bilateral pubertal gynecomastia but not when red flags such as bloody discharge are present
  • Serum beta-hCG and testosterone — part of the workup for true bilateral gynecomastia to evaluate hCG-secreting germ cell tumors or hypogonadism, but imaging takes priority for a focal mass with bloody discharge
  • Mammography — the initial study for an indeterminate breast mass in men 25 and older; ACR also rates it appropriate at any age when the exam is suspicious for cancer, but in a 15-year-old, in whom breast cancer is exceedingly rare, ultrasound comes first and mammography is added if the ultrasound findings are suspicious
  • Core needle biopsy of the mass — tempting because a firm, eccentric mass with bloody discharge raises concern for a discrete lesion, but tissue sampling follows imaging rather than replacing it; ultrasound first characterizes the mass without radiation and determines whether and where a biopsy is needed.

Additional high-yield points

  • Bloody nipple discharge in any patient, male or female, is never physiologic and always requires imaging
Question 2ReproductiveMedium
A 22-year-old woman presents with 5 days of yellow vaginal discharge and mild dysuria. She has a new sexual partner and inconsistent condom use. She denies abdominal pain, fever, or abnormal bleeding. Temperature 37.0 C, BP 118/74 mm Hg. Pelvic exam shows mucopurulent cervical discharge without cervical motion tenderness. Nucleic acid amplification testing of a vaginal swab is positive for Chlamydia trachomatis and negative for Neisseria gonorrhoeae. Urine pregnancy test is negative. Which of the following is the recommended first-line treatment?
  • AMetronidazole 500 mg orally twice daily for 7 days
  • BDoxycycline 100 mg orally twice daily for 7 days
  • CCeftriaxone 500 mg intramuscularly once
  • DAmoxicillin 500 mg orally 3 times daily for 7 days
  • EAzithromycin 1 g orally once
Reveal answer & full explanation
Correct answer: B — Doxycycline 100 mg orally twice daily for 7 days
  • AMetronidazole 500 mg orally twice daily for 7 days
  • BDoxycycline 100 mg orally twice daily for 7 days✓
  • CCeftriaxone 500 mg intramuscularly once
  • DAmoxicillin 500 mg orally 3 times daily for 7 days
  • EAzithromycin 1 g orally once

Why Doxycycline 100 mg orally twice daily for 7 days is correct

  • Doxycycline 100 mg orally twice daily for 7 days is the current CDC first-line treatment for uncomplicated urogenital Chlamydia trachomatis infection in nonpregnant adults (2021 STI Treatment Guidelines)
  • Microbiologic cure rates with doxycycline are superior to single-dose azithromycin (approximately 97% vs 94%)
  • Azithromycin failures are substantially higher for rectal chlamydia specifically

Why the others are wrong

  • Azithromycin 1 g orally once — previously co-first-line and still acceptable when adherence is a concern or in pregnancy, but no longer the preferred regimen because of inferior efficacy
  • Ceftriaxone 500 mg intramuscularly once — first-line for gonorrhea, not chlamydia; would be added if NAAT were positive for N. gonorrhoeae or empirically when gonorrhea cannot be excluded
  • Metronidazole 500 mg orally twice daily for 7 days — covers trichomoniasis and bacterial vaginosis, not chlamydia
  • Amoxicillin 500 mg orally 3 times daily for 7 days — an alternative regimen for chlamydia in pregnancy, which tempts students treating a woman of reproductive age, but her pregnancy test is negative and amoxicillin is not a recommended regimen for nonpregnant adults, in whom doxycycline is preferred

Additional high-yield points

  • Sexual partners within the past 60 days should be evaluated and treated
  • The patient should abstain from intercourse for 7 days after starting therapy
  • Test of reinfection (not test of cure) is recommended at 3 months
Question 3ReproductiveMedium
A 52-year-old woman presents for a routine well-woman visit. Three years ago she underwent supracervical (partial) hysterectomy with retention of the cervix for symptomatic fibroids. She has no history of abnormal cervical cytology, is up to date on HPV vaccination, and is sexually active with one partner. BP 122/76 mm Hg, BMI 26 kg/m2. Pelvic exam reveals a normal-appearing cervix. She asks whether she still needs cervical cancer screening. Which of the following is the most appropriate recommendation regarding cervical cancer screening?
  • ADiscontinue all screening
  • BHPV testing every 3 years
  • CCytology testing every 5 years
  • DContinue age-based screening
  • EAnnual cytology screening
Reveal answer & full explanation
Correct answer: D — Continue age-based screening
  • ADiscontinue all screening
  • BHPV testing every 3 years
  • CCytology testing every 5 years
  • DContinue age-based screening✓
  • EAnnual cytology screening

Why Continue age-based screening is correct

  • This patient had a supracervical (partial) hysterectomy, meaning the cervix is intact and remains at risk for HPV-driven cervical neoplasia
  • She should continue routine cervical cancer screening according to standard age-based guidelines (e.g., USPSTF: cytology every 3 years, or HPV testing alone or co-testing every 5 years for ages 30-65; ACS: primary HPV testing every 5 years for ages 25-65)

Why the others are wrong

  • Discontinue all screening — applies only to women who have had a TOTAL hysterectomy (cervix removed) for benign indications AND no history of high-grade cervical dysplasia or cervical cancer; this patient retains her cervix
  • HPV testing every 3 years — a real modality at the wrong interval; clinician-collected primary HPV testing repeats every 5 years, and the 3-year interval applies only after a negative self-collected sample (ACS 2025), which this stem does not describe
  • Annual cytology screening — no longer recommended for any age group because of overdiagnosis of transient HPV-related changes
  • Cytology testing every 5 years — cytology is a valid screening test for her retained cervix, but the 5-year interval belongs to HPV-based screening (primary HPV testing or co-testing); cytology alone is repeated every 3 years because a single Pap test is less sensitive for high-grade lesions

Additional high-yield points

  • Key teaching point: always clarify supracervical vs total hysterectomy before counseling on screening cessation
Question 4ReproductiveMedium
A 26-year-old sexually active woman presents to the emergency department with 4 days of worsening right lower quadrant and pelvic pain, fever, and vaginal discharge. She has a history of chlamydial cervicitis. On examination temperature is 38.9°C, there is right adnexal and cervical motion tenderness, and a tender fullness is palpated in the right adnexa. Urine beta-hCG is negative and WBC is 18,000/mm3. Transvaginal ultrasound shows a 6 cm complex, thick-walled, multiloculated right adnexal mass. Which of the following is the most likely diagnosis?
  • ATubo-ovarian abscess
  • BOvarian cyst rupture
  • CAcute appendicitis
  • DOvarian torsion
  • ERuptured ectopic pregnancy
Reveal answer & full explanation
Correct answer: A — Tubo-ovarian abscess
  • ATubo-ovarian abscess✓
  • BOvarian cyst rupture
  • CAcute appendicitis
  • DOvarian torsion
  • ERuptured ectopic pregnancy

Why Tubo-ovarian abscess is correct

  • Tubo-ovarian abscess is a complication of ascending pelvic inflammatory disease; the prior chlamydial infection, fever, cervical motion and adnexal tenderness, and leukocytosis establish the infectious picture.
  • The discriminating finding is a complex, thick-walled, multiloculated adnexal mass on ultrasound, representing the walled-off abscess.
  • Management is inpatient broad-spectrum IV antibiotics (such as cefotetan or cefoxitin plus doxycycline, or clindamycin plus gentamicin), with drainage for large abscesses, rupture, or failure to improve within 48-72 hours.

Why the others are wrong

  • Ovarian cyst rupture — causes sudden unilateral pain and may show free fluid, but it does not produce sustained fever, marked leukocytosis, and a thick-walled multiloculated mass (anchoring on acute adnexal pain).
  • Ovarian torsion — presents with abrupt severe pain, nausea, and an enlarged edematous ovary with reduced Doppler flow, not a thick-walled abscess with high fever and a PID history (premature closure on the most time-critical adnexal emergency).
  • Ruptured ectopic pregnancy — is excluded by the negative beta-hCG; it would present with a positive pregnancy test, an empty uterus, and hemoperitoneum (buzzword-matching on adnexal mass plus pain).
  • Acute appendicitis — right lower quadrant pain, fever, and leukocytosis fit appendicitis, but the prior chlamydial infection, cervical motion and adnexal tenderness, and a thick-walled multiloculated adnexal mass localize the process to the adnexa; appendicitis would typically show a noncompressible, dilated appendix rather than a complex adnexal mass (premature closure on the most common surgical cause of RLQ pain).
Question 5ReproductiveMedium
A 32-year-old woman presents with 3 days of vulvar itching, burning, and thick white discharge. She was started on azithromycin 5 days ago for community-acquired pneumonia and takes quetiapine nightly for bipolar disorder. Pelvic exam reveals erythematous vulva with curd-like discharge; KOH prep shows pseudohyphae and budding yeast. ECG from her last admission showed a QTc of 470 ms. Which of the following is the most appropriate treatment?
  • AIntravaginal clotrimazole
  • BOral fluconazole
  • COral itraconazole
  • DIntravaginal boric acid
  • EIntravaginal metronidazole
Reveal answer & full explanation
Correct answer: A — Intravaginal clotrimazole
  • AIntravaginal clotrimazole✓
  • BOral fluconazole
  • COral itraconazole
  • DIntravaginal boric acid
  • EIntravaginal metronidazole

Why Intravaginal clotrimazole is correct

  • This patient has uncomplicated vulvovaginal candidiasis: vulvar itching and burning, curd-like discharge, and a KOH prep showing pseudohyphae and budding yeast
  • The decisive issue is medication-related QT risk — azithromycin and quetiapine both prolong the QT interval, and her baseline QTc is already borderline-prolonged at 470 ms
  • Intravaginal azoles (clotrimazole, miconazole, terconazole) are highly effective for uncomplicated candidiasis and have minimal systemic absorption, so they avoid additive QT prolongation
  • For uncomplicated disease, topical and oral azoles achieve similar clinical cure rates (Cochrane review, Denison 2020), and CDC 2021 lists both routes as recommended, so safety is the tie-breaker and the topical agent is the most appropriate choice

Why the others are wrong

  • Intravaginal metronidazole — treats bacterial vaginosis (the vaginal gel is not adequate for trichomoniasis, which needs an oral nitroimidazole such as metronidazole or tinidazole) and has no activity against Candida; buzzword-match trap, since 'vaginal discharge' pattern-matches to metronidazole but the KOH pseudohyphae and budding yeast identify yeast, not clue cells or motile trichomonads
  • Oral itraconazole — a strong CYP3A4 inhibitor that would sharply raise quetiapine levels (the quetiapine label calls for cutting the dose to one-sixth with strong CYP3A4 inhibitors), so its torsades risk here is at least as high as fluconazole's; it is also not a CDC-recommended regimen for vulvovaginal candidiasis; right-diagnosis-wrong-route trap
  • Oral fluconazole — CDC 2021 does list single-dose fluconazole 150 mg PO as a recommended regimen, but picking it treats azithromycin, quetiapine and the 470 ms QTc as background when they are the decision-changers: fluconazole prolongs QT via IKr (hERG) inhibition and, as a moderate CYP3A4 inhibitor, can raise quetiapine levels, and the US Diflucan label contraindicates coadministration with QT-prolonging drugs metabolized by CYP3A4, a class description quetiapine fits. One dose is low absolute risk on its own, but here it stacks on two QT-prolonging drugs (azithromycin's half-life of about 68 h keeps it on board) and a borderline-prolonged QTc, when an equally recommended topical azole avoids nearly all of that risk; premature-closure trap
  • Intravaginal boric acid — a vaginal therapy, which makes it tempting given her QT risk, but boric acid is reserved for non-albicans (especially Candida glabrata) or azole-refractory infection; pseudohyphae on KOH point to Candida albicans, and uncomplicated candidiasis is treated first-line with an azole; right-route-wrong-drug trap
Question 6ReproductiveMedium
A 34-year-old G3P3 woman is on postpartum day 4 following a vaginal delivery complicated by a 4-hour second stage and a third-degree perineal laceration. She reports persistent vaginal bleeding heavier than expected, soaking one pad every 2 hours, with passage of small clots. Vitals: T 99.1°F, HR 102, BP 110/64. Exam reveals a boggy, poorly contracted uterus palpable above the umbilicus with no perineal hematoma. Hemoglobin has dropped from 11.2 to 8.4 g/dL. Pelvic ultrasound shows an enlarged uterus without retained products. Which of the following is the most likely complication?
  • ACervical laceration
  • BCoagulopathy
  • CEndometritis
  • DPerineal dehiscence
  • EUterine atony
Reveal answer & full explanation
Correct answer: E — Uterine atony
  • ACervical laceration
  • BCoagulopathy
  • CEndometritis
  • DPerineal dehiscence
  • EUterine atony✓

Why Uterine atony is correct

  • This patient has secondary postpartum hemorrhage (occurring between 24 hours and 12 weeks postpartum); the boggy, poorly contracted, enlarged uterus on exam points to inadequate myometrial tone from subinvolution of the placental site, best captured among these options by uterine atony
  • Poor uterine tone is the single most common driver of postpartum hemorrhage overall (about 70-80% of primary cases)
  • A risk factor present here is the prolonged second stage, which impairs myometrial contraction (grand multiparity means 5 or more births, so it does not apply to this G3P3 patient)
  • The clinical hallmark is a uterus that feels soft and fails to firm with bimanual massage

Why the others are wrong

  • Endometritis — the other classic cause of secondary postpartum hemorrhage, but it is diagnosed by fever above 100.4°F with uterine tenderness, usually with malodorous lochia; this woman is afebrile at 99.1°F and no uterine tenderness or foul lochia is described
  • Coagulopathy — would present with bleeding from multiple sites (IV sites, gums) and abnormal coagulation studies rather than an isolated boggy uterus
  • Cervical laceration — bleeds briskly from a visible tear beginning at delivery while the uterus stays firm and well contracted, so it cannot explain a boggy enlarged fundus on postpartum day 4
  • Perineal dehiscence — tempting because her third-degree laceration repair is a fresh wound that can break down in the days after delivery, but perineal wound dehiscence presents with perineal pain, discharge, and visible separation of the repair with modest bleeding, not heavy clotted bleeding from a boggy, enlarged uterus palpable above the umbilicus

Additional high-yield points

  • Initial treatment of atony includes bimanual uterine massage and uterotonics such as oxytocin, methylergonovine, or carboprost
Question 7ReproductiveMedium
A 64-year-old G4P4 postmenopausal woman presents with a 6-month history of vaginal pressure and a sensation that 'something is falling out' that worsens with prolonged standing and improves when she lies down. She also reports needing to splint the posterior vaginal wall to complete bowel movements. She had four vaginal deliveries, the largest infant weighing 4,200 g. On pelvic examination with Valsalva, the cervix descends to 3 cm beyond the hymen without complete vaginal eversion. Which of the following is the most likely diagnosis?
  • AStage I uterine prolapse
  • BStage II uterine prolapse
  • CCystocele
  • DStage IV uterine prolapse
  • EStage III uterine prolapse
Reveal answer & full explanation
Correct answer: E — Stage III uterine prolapse
  • AStage I uterine prolapse
  • BStage II uterine prolapse
  • CCystocele
  • DStage IV uterine prolapse
  • EStage III uterine prolapse✓

Why Stage III uterine prolapse is correct

  • Pelvic organ prolapse is staged by the POP-Q system using the most distal point of the leading edge relative to the hymen.
  • Stage 0 = no descent; stage I = leading edge more than 1 cm above the hymen; stage II = leading edge within 1 cm of the hymen; stage III = leading edge more than 1 cm beyond the hymen without complete eversion; stage IV = complete eversion.
  • This patient's cervix descends to 3 cm beyond the hymen with bulge symptoms and obstructed defecation, placing the leading edge well beyond +1 cm and consistent with stage III.

Why the others are wrong

  • Stage I uterine prolapse — describes a leading edge more than 1 cm above the hymen and would not produce a visible bulge or symptoms; choosing it under-stages the obvious protrusion beyond the hymen.
  • Stage II uterine prolapse — describes a leading edge within 1 cm above or below the hymen; a cervix reaching 3 cm past the hymen lies well outside that window, so this under-stages the measured descent.
  • Cystocele — anterior vaginal wall prolapse from bladder descent; her posterior splinting may reflect a coexisting defect, but the leading point is the cervix, so anchoring on a compartment defect misses the primary uterine prolapse.
  • Stage IV uterine prolapse — tempting because the cervix protrudes well past the hymen, but stage IV requires complete eversion of the vagina (procidentia); a cervix reaching 3 cm beyond the hymen without complete eversion is stage III, so this over-stages the measured descent.
Question 8ReproductiveMedium
A 30-year-old woman has 2 years of worsening dysmenorrhea and deep dyspareunia. Transvaginal ultrasound shows bilateral ovarian cysts with homogeneous low-level internal echoes (chocolate cysts), and diagnostic laparoscopy confirms endometriosis. Which of the following is the most appropriate first-line medical therapy?
  • ALeuprolide GnRH agonist therapy
  • BNaproxen NSAID monotherapy
  • CCombined oral contraceptives
  • DDanazol androgenic steroid therapy
  • ELetrozole aromatase inhibitor
Reveal answer & full explanation
Correct answer: C — Combined oral contraceptives
  • ALeuprolide GnRH agonist therapy
  • BNaproxen NSAID monotherapy
  • CCombined oral contraceptives✓
  • DDanazol androgenic steroid therapy
  • ELetrozole aromatase inhibitor

Why Combined oral contraceptives is correct

  • Combined oral contraceptive pills (OCPs) and progestins are first-line medical therapy for endometriosis-associated pain and suppress cyclic endometrial stimulation
  • They are well tolerated for long-term use, are inexpensive, and provide contraception in a patient who is not currently seeking pregnancy
  • Per current ACOG and ESHRE guidance, combined hormonal contraceptives or progestins are the recommended initial hormonal therapy after confirmed or presumed endometriosis
  • Definitive surgery (hysterectomy with bilateral salpingo-oophorectomy) is reserved for severe disease after childbearing is complete, not initial therapy

Why the others are wrong

  • Leuprolide GnRH agonist therapy — a GnRH agonist reserved for pain refractory to first-line hormonal therapy and requiring add-back therapy to limit hypoestrogenic side effects and bone loss; right class, wrong step.
  • Danazol androgenic steroid therapy — an androgenic agent that is effective but now rarely used because of hirsutism, weight gain, and other androgenic effects; an outdated buzzword answer, not current first-line.
  • Naproxen NSAID monotherapy — an NSAID that relieves dysmenorrhea pain but does not suppress the underlying disease, so it is an adjunct rather than definitive medical therapy; anchoring on the pain symptom.
  • Letrozole aromatase inhibitor — an aromatase inhibitor that lowers estrogen and reduces endometriosis pain, which is why it tempts, but in a premenopausal woman it raises FSH and stimulates the ovaries (it is used for ovulation induction), so it is paired with a progestin, combined hormonal contraceptive, or GnRH analog, and ESHRE reserves it for pain refractory to other medical or surgical treatment; a later-line option, not first-line.
Question 9ReproductiveMedium
A 55-year-old woman presents 18 months after menopause with vaginal bleeding. Her BMI is 38 kg/m2, and she has hypertension and type 2 diabetes mellitus. Endometrial biopsy shows a grade 1 endometrioid adenocarcinoma, and preoperative evaluation shows disease confined to the endometrium without myometrial invasion or extrauterine spread. Which of the following is the most appropriate definitive treatment?
  • APlatinum-based adjuvant chemotherapy
  • BHysterectomy with salpingo-oophorectomy
  • CRadical hysterectomy with pelvic lymphadenectomy
  • DContinuous high-dose oral progestin therapy
  • EExternal beam whole-pelvic radiation
Reveal answer & full explanation
Correct answer: B — Hysterectomy with salpingo-oophorectomy
  • APlatinum-based adjuvant chemotherapy
  • BHysterectomy with salpingo-oophorectomy✓
  • CRadical hysterectomy with pelvic lymphadenectomy
  • DContinuous high-dose oral progestin therapy
  • EExternal beam whole-pelvic radiation

Why Hysterectomy with salpingo-oophorectomy is correct

  • Total hysterectomy with bilateral salpingo-oophorectomy is the definitive, curative treatment for stage I endometrioid endometrial carcinoma
  • This grade 1 tumor confined to the endometrium is stage IA, which carries a >90% 5-year survival after surgery
  • Surgery also provides definitive staging, including sentinel lymph node assessment, to guide any adjuvant therapy
  • Risk factors here (obesity, diabetes, unopposed estrogen exposure) are typical, and postmenopausal bleeding must be treated as cancer until proven otherwise

Why the others are wrong

  • Continuous high-dose oral progestin therapy — a fertility-sparing option reserved for young patients wishing to preserve the uterus or for poor surgical candidates; in a 55-year-old it is not definitive and undertreats the cancer (right-treatment-wrong-patient)
  • Platinum-based adjuvant chemotherapy — reserved for advanced, high-grade, or metastatic disease; using it as primary therapy for stage IA grade 1 disease is right-treatment-wrong-stage
  • External beam whole-pelvic radiation — primary radiation is used only when a patient cannot undergo surgery; here it is not the definitive first treatment and is at most adjuvant
  • Radical hysterectomy with pelvic lymphadenectomy — the standard operation for early-stage cervical cancer, and its extent can make it look like the most thorough cancer surgery, but stage IA grade 1 endometrioid cancer is treated with total hysterectomy and bilateral salpingo-oophorectomy, usually with sentinel lymph node mapping for staging; parametrial resection adds bladder and ureteral morbidity without benefit, and routine full lymphadenectomy has not improved survival in early-stage disease (right-surgery-wrong-cancer)
Question 10ReproductiveMedium
A 32-year-old woman at 36 weeks gestation has a blood pressure of 156/102 mm Hg confirmed on two readings 4 hours apart, 3+ proteinuria on dipstick, a serum creatinine of 1.3 mg/dL, and a new persistent headache. Which of the following is the most likely diagnosis?
  • APreeclampsia without severe features
  • BPreeclampsia with severe features
  • CGestational hypertension
  • DHELLP (hemolysis, elevated liver enzymes, low platelets) syndrome
  • EChronic hypertension
Reveal answer & full explanation
Correct answer: B — Preeclampsia with severe features
  • APreeclampsia without severe features
  • BPreeclampsia with severe features✓
  • CGestational hypertension
  • DHELLP (hemolysis, elevated liver enzymes, low platelets) syndrome
  • EChronic hypertension

Why preeclampsia with severe features is correct

  • After 20 weeks gestation this patient has new hypertension (156/102 mm Hg on two readings) plus 3+ proteinuria, establishing preeclampsia.
  • Severe features are present: a serum creatinine of 1.3 mg/dL indicates renal insufficiency (>1.1 mg/dL) and the new persistent headache is a cerebral symptom — either one alone upgrades the diagnosis to severe features. Note that 156/102 mm Hg is below the severe-range threshold (>=160/110), so the severity here derives from the renal insufficiency and headache, not the blood pressure itself.
  • Management is magnesium sulfate for seizure prophylaxis, IV labetalol or hydralazine for sustained severe-range pressures, and delivery as the definitive treatment.

Why the others are wrong

  • Chronic hypertension — defined by elevated blood pressure before 20 weeks or pre-pregnancy; it does not produce new proteinuria, renal insufficiency, or headache at 36 weeks. Sets the anchoring trap of fixating on the blood pressure alone.
  • Gestational hypertension — new hypertension after 20 weeks but WITHOUT proteinuria or end-organ involvement; the 3+ proteinuria and creatinine of 1.3 mg/dL exclude it. Sets the premature-closure trap of stopping at the mildest diagnosis.
  • HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome — requires laboratory evidence of hemolysis, transaminitis, and thrombocytopenia, none of which is reported here. Sets the buzzword trap of jumping to the most dramatic preeclampsia variant without its defining labs.
  • Preeclampsia without severe features — tempting because 156/102 mm Hg is below the severe-range threshold of 160/110, but severity can come from end-organ findings alone; the creatinine of 1.3 mg/dL and the new persistent headache each qualify as severe features. Sets the trap of grading severity by blood pressure alone.

That's 10 of 7,700+. Get the rest.

Unlock the full FirstPassPA bank: 7,700+ board-style questions across every organ system, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → See today's free PANCE question →

Reproductive PANCE practice: FAQ

Are these Reproductive PANCE practice questions free?

Yes. Each question shows the full vignette, the correct answer, and a complete explanation, with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, flashcards, and an AI tutor.

How much of the PANCE is Reproductive?

Reproductive makes up 7% of the PANCE content blueprint. FirstPassPA's timed PANCE exams are dealt to the same weights, so a practice exam carries the same share of Reproductive questions.

How should I use these questions?

Attempt each vignette before you reveal the answer, then read the full explanation even when you got it right: the reasons each wrong choice is wrong are where most of the learning is. When you are ready for more, practice Reproductive questions in the app, or take a full timed PANCE practice exam dealt to the blueprint weights.

Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.